MEI Pharma, Inc. - stock earnings
MEIP Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -11.1 million USD | ? USD |
| 2023Q3 | 56.4 million USD | 65.3 million USD |
| 2023Q2 | -10.0 million USD | 1.5 million USD |
| 2023Q1 | -14.5 million USD | 5.9 million USD |
| 2022Q4 | 10.3 million USD | 32.7 million USD |
| 2022Q3 | -17.1 million USD | 8.7 million USD |
| 2022Q2 | -16.3 million USD | 11.4 million USD |
| 2022Q1 | -25.6 million USD | 8.1 million USD |
| 2021Q4 | -5.8 million USD | 18.2 million USD |
| 2021Q3 | -11.9 million USD | 13.4 million USD |
| 2021Q2 | -5.7 million USD | 10.1 million USD |
| 2021Q1 | -31.3 million USD | 2.4 million USD |
| 2020Q4 | -11.5 million USD | 9.2 million USD |
| 2020Q3 | -2.1 million USD | 3.8 million USD |
| 2020Q2 | -18.5 million USD | 25.5 million USD |
| 2020Q1 | -4.3 million USD | 1.2 million USD |
| 2019Q4 | -20.2 million USD | 1.0 million USD |
| 2019Q3 | -3.0 million USD | 1.2 million USD |
| 2019Q2 | 3.1 million USD | 1.1 million USD |
| 2019Q1 | -17.4 million USD | 1.2 million USD |
| 2018Q4 | 12.0 million USD | 2.0 million USD |
| 2018Q3 | -14.5 million USD | 488000 USD |
| 2018Q2 | -19.3 million USD | 548000 USD |
| 2018Q1 | -5.9 million USD | 433000 USD |
| 2017Q4 | -6.1 million USD | 358000 USD |
| 2017Q3 | -8.8 million USD | 283000 USD |
| 2017Q2 | -4.3 million USD | 449000 USD |
| 2017Q1 | -602000 USD | 4.5 million USD |
| 2016Q4 | 11.9 million USD | 17.2 million USD |
| 2016Q3 | -4.3 million USD | 1.1 million USD |
| 2016Q2 | -5.8 million USD | ? USD |
| 2016Q1 | -5.4 million USD | ? USD |
| 2015Q4 | -5.1 million USD | ? USD |
| 2015Q3 | -4.6 million USD | -94000 USD |
| 2015Q2 | -5.7 million USD | ? USD |
| 2015Q1 | -8.9 million USD | ? USD |
| 2014Q4 | -9.1 million USD | ? USD |
| 2014Q3 | -9.0 million USD | ? USD |
| 2014Q2 | -8.5 million USD | ? USD |
| 2014Q1 | -7.4 million USD | ? USD |
| 2013Q4 | -6.3 million USD | ? USD |
| 2013Q3 | -4.9 million USD | ? USD |
| 2013Q2 | -3.2 million USD | ? USD |
| 2013Q1 | -2.8 million USD | ? USD |
| 2012Q4 | -2.8 million USD | ? USD |
| 2012Q3 | -2.5 million USD | ? USD |
| 2012Q2 | -2.1 million USD | ? USD |
| 2012Q1 | -2.3 million USD | ? USD |
| 2011Q4 | -1.5 million USD | ? USD |
| 2011Q3 | -1.6 million USD | ? USD |
| 2011Q2 | -1.6 million USD | ? USD |
| 2011Q1 | -1.3 million USD | ? USD |
| 2010Q4 | -1.8 million USD | 71000 USD |
| 2010Q3 | -1.8 million USD | 71000 USD |
| 2010Q2 | -1.8 million USD | 16000 USD |
| 2010Q1 | -1.8 million USD | 16000 USD |
| 2009Q4 | -2.2 million USD | 19000 USD |
| 2009Q3 | -1.4 million USD | 23000 USD |
| 2009Q2 | -5.4 million USD | 27000 USD |
| 2009Q1 | -1.9 million USD | 29000 USD |
| 2008Q4 | -1.9 million USD | 29000 USD |
| 2008Q3 | -1.6 million USD | 76000 USD |
| 2008Q2 | -3.4 million USD | 92000 USD |
| 2008Q1 | -3.3 million USD | 149000 USD |
| 2007Q4 | -2.3 million USD | 215000 USD |
| 2007Q3 | -3.4 million USD | 218000 USD |
| 2007Q2 | -2.0 million USD | 156000 USD |
| 2007Q1 | -1.7 million USD | 171000 USD |
| 2006Q4 | -2.2 million USD | 183000 USD |
| 2006Q3 | -7.9 million USD | 135000 USD |
| 2006Q2 | -553000 USD | -473000 USD |
| 2006Q1 | -3.3 million USD | 101000 USD |
| 2005Q4 | -1.8 million USD | 130000 USD |
| 2005Q3 | -1.8 million USD | 122000 USD |
| 2005Q2 | -2.1 million USD | 187000 USD |
| 2005Q1 | -1.7 million USD | 71000 USD |
| 2004Q4 | -1.4 million USD | 64000 USD |
| 2004Q3 | -1.2 million USD | 67000 USD |
| 2004Q2 | -1.2 million USD | 72000 USD |
| 2004Q1 | -1.5 million USD | 75000 USD |
| 2003Q4 | -4.7 million USD | ? USD |
| 2003Q3 | -1.1 million USD | ? USD |
| 2003Q2 | -1.2 million USD | 30000 USD |
| 2003Q1 | -597000 USD | 36000 USD |
| 2002Q4 | -720000 USD | 40000 USD |
| 2002Q3 | -530000 USD | 40000 USD |
MEIP Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -31.8 million USD | 48.8 million USD |
| 2022 | -54.7 million USD | 40.7 million USD |
| 2021 | -50.6 million USD | 25.5 million USD |
| 2020 | -46.0 million USD | 28.9 million USD |
| 2019 | -16.8 million USD | 4.9 million USD |
| 2018 | -40.1 million USD | 1.6 million USD |
| 2017 | 2.7 million USD | 23.2 million USD |
| 2016 | -20.9 million USD | ? USD |
| 2015 | -32.7 million USD | ? USD |
| 2014 | -27.1 million USD | ? USD |
| 2013 | -11.2 million USD | ? USD |
| 2012 | -7.5 million USD | ? USD |
| 2011 | -6.8 million USD | ? USD |
| 2010 | -7.9 million USD | 84000 USD |
| 2009 | -11.2 million USD | 228000 USD |
| 2008 | -12.4 million USD | 674000 USD |
| 2007 | -13.8 million USD | 645000 USD |
| 2006 | -7.4 million USD | -120000 USD |
| 2005 | -6.4 million USD | 308000 USD |
| 2004 | -8.5 million USD | 193000 USD |
| 2003 | -3.0 million USD | 145000 USD |
| 2002 | -123000 USD | 7000 USD |
MEIP
Price: $3.06
52 week price:
Payout Ratio Range:
Earnings Per Share: 2.98 USD
P/E Ratio: 0.74
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 480786
Ebitda: -6.2 millionMarket Capitalization: 21.7 million